Annexon Biosciences
The Director, Quality Systems at Annexon Biosciences provides strategic leadership and hands-on oversight for the design, implementation, maintenance, and continuous improvement of the Quality Management System (QMS). This role serves as a subject matter expert for GxP quality systems and is accountable for system governance, compliance, and operational excellence across electronic quality platforms.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2011
Annexon Biosciences is a biopharmaceutical company developing next‑generation complement therapies by targeting C1q, the initiating molecule of the classical complement pathway. By blocking C1q, Annexon aims to prevent downstream immune‑mediated damage in autoimmune, neurodegenerative (including Alzheimer’s and Huntington’s) and ophthalmic diseases affecting the body, brain, and eye. The company advances C1q‑targeted biologics through a pipeline of therapeutic candidates intended to provide disease‑modifying treatments for conditions driven by classical complement activation.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Annexon Biosciences.
13% above the average for this role
Annexon Biosciences stock rating reiterated by Cantor Fitzgerald
Jan 14, 2026
GxP Training Facilitation Specialist
Incognito Software Systems
Senior Manager GxP Systems & Validation
Arrowhead Pharmaceuticals
Senior Manager, IT Qualification & Validation
Arcus Biosciences
Solution Architect - Quality (QMS)
Kivo
Senior Validation Engineer
Verista, Inc.
Senior Validation Engineer
Verista, Inc.